BioNTech SE
BNTX
$92.80
-$0.87-0.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 120.55M | 135.53M | 1.06B | 1.78B | 295.99M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 120.55M | 135.53M | 1.06B | 1.78B | 295.99M |
| Cost of Revenue | 110.73M | 81.94M | 352.49M | 173.38M | 86.71M |
| Gross Profit | 9.82M | 53.59M | 703.81M | 1.60B | 209.28M |
| SG&A Expenses | 225.80M | 173.06M | 253.66M | 173.61M | 155.94M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 211.76M | 22.84M | 214.08M | 807.04M | -36.20M |
| Total Operating Expenses | 1.09B | 917.04M | 1.41B | 1.81B | 784.24M |
| Operating Income | -972.37M | -781.51M | -352.26M | -38.58M | -488.25M |
| Income Before Tax | -980.25M | -651.94M | -264.72M | 28.88M | -457.04M |
| Income Tax Expenses | -43.26M | -41.54M | 90.33M | 62.43M | -18.27M |
| Earnings from Continuing Operations | -936.99M | -610.40M | -355.05M | -33.55M | -438.76M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -936.99M | -610.40M | -355.05M | -33.55M | -438.76M |
| EBIT | -972.37M | -781.51M | -352.26M | -38.58M | -488.25M |
| EBITDA | -668.61M | -642.30M | -310.76M | 106.62M | -430.37M |
| EPS Basic | -3.70 | -2.41 | -1.46 | -0.14 | -1.82 |
| Normalized Basic EPS | -2.19 | -1.61 | -0.62 | 0.12 | -1.09 |
| EPS Diluted | -3.70 | -2.41 | -1.46 | -0.14 | -1.82 |
| Normalized Diluted EPS | -2.19 | -1.61 | -0.62 | 0.12 | -1.09 |
| Average Basic Shares Outstanding | 253.33M | 253.29M | 244.00M | 239.17M | 241.63M |
| Average Diluted Shares Outstanding | 253.33M | 253.29M | 244.00M | 239.17M | 241.63M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |